Cargando…
Osteosarcoma: prognosis plateau warrants retinoblastoma pathway targeted therapy
Osteosarcoma (OS) is the most common primary bone cancer in children and adolescents, affecting ~560 young patients in the United States annually. The term OS describes a diverse array of subtypes with varying prognoses, but the majority of tumors are high grade and aggressive. Perhaps because the t...
Autores principales: | Ballatori, Sarah E, Hinds, Philip W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657420/ https://www.ncbi.nlm.nih.gov/pubmed/29263893 http://dx.doi.org/10.1038/sigtrans.2016.1 |
Ejemplares similares
-
A Role for the Retinoblastoma Protein As a Regulator of Mouse Osteoblast Cell Adhesion: Implications for Osteogenesis and Osteosarcoma Formation
por: Sosa-García, Bernadette, et al.
Publicado: (2010) -
Ozone Therapy as Adjuvant for Cancer Treatment: Is Further Research Warranted?
por: Clavo, Bernardino, et al.
Publicado: (2018) -
Targeting the VEGF Pathway in Osteosarcoma
por: Assi, Tarek, et al.
Publicado: (2021) -
“Warranted” Dental Treatment
por: Schwamm, Henry
Publicado: (1914) -
The Army Medical Warrant
Publicado: (1876)